[CANCELLED] Progress in Precision Diabetes Diagnosis and Treatment
Thursday, January 18, 2018
12:00 pm - 1:00 pm
Duke Medical Pavilion Room 2W96
Toni Pollin, MS, PhD, CGC
Toni Pollin is a PhD human geneticist and board certified genetic counselor. Her research interests lie in using epidemiological and statistical methods to map genes involved in susceptibility to type 2 diabetes and related complications, particularly related to lipids and cardiovascular disease, and clinical translation of emerging genetics findings into clinical uses. Her current major research efforts involve an NHGRI-funded implementation study of a program designed to screen for, diagnose and promote individualized therapy for highly penetrant genetic forms of diabetes, co-leadership of an NICHD-funded ClinGen monogenic diabetes expert variant curation panel, studying gene x lifestyle/ pharmaceutical interactions in the Diabetes Prevention Program (a multi-center, multi-ethnic clinical trial showing reduction in diabetes incidence using metformin or intensive lifestyle changes, characterizing the metabolic and cardioprotective effects of inborn apolipoprotein C-III deficiency resulting from a founder mutation in the Old Order Amish, and the genetics and pharmacogenetics of diabetes in children and adolescents in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. She also leads the Amish Wellness Study, a study designed to assemble a community based Amish biobank while providing basic health screening to the Lancaster Amish population, and provides genetic analysis expertise to colleagues across campus.